Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Cigna Ends Coverage of GLP-1 Obesity Drugs for Staff

Summary by Newsmax
Effective July 1, according to materials, health insurer Cigna will stop ‌covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee health plan.
DisclaimerRead with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.

1 Articles

NewsmaxNewsmax
Right

Cigna Ends Coverage of GLP-1 Obesity Drugs for Staff

Effective July 1, according to materials, health insurer Cigna will stop ‌covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee health plan.

·Washington, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Newsmax broke the news in Washington, United States on Tuesday, June 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cigna icon

Cigna

Novo Nordisk icon

Novo Nordisk

GLP-1 icon

GLP-1

Eli Lilly icon

Eli Lilly

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal